Detailed Narrative
Robust Financial Performance in FY25
Excel Industries demonstrated strong financial recovery in FY25, with net operating revenues growing 18% year-over-year to ₹978 crores, up from ₹826 crores in FY24. This growth was significantly driven by volume. EBITDA saw a remarkable 400% increase to ₹121 crores, leading to an improved EBITDA margin of 12.3% for the full year, compared to 2.9% in FY24. Profit after tax also surged by 453% to ₹84 crores, reflecting enhanced operational efficiency and demand revival.
Strategic Focus on Specialty Chemicals and Diversification
The company has successfully transitioned into a specialty chemicals entity, with agrochemical intermediates now comprising 50-60% of its portfolio, specialty chemicals 20-30%, polymer additives 5-8%, and pharma intermediates/API 4-8%. While phosphorus chemistry remains a core strength, accounting for 80% of revenues, Excel is actively developing a portfolio of biocides and exploring other chemistries to diversify its product offerings and reduce concentration risks. This strategy aims to leverage existing technical capabilities and market positions.
Key Growth Initiatives and Capacity Expansion
Excel Industries is executing several strategic growth initiatives. A capacity expansion for one of its biocides is underway, involving an investment of ₹10.3 crores to double its capacity, with completion expected by H2 FY26. The company has also secured a long-term supply contract with a multinational company, with supplies projected to commence in Q2 FY26. Furthermore, a new corporate R&D center, requiring approximately ₹15 crores in capital expenditure, is targeted to be operational in H1 FY26 to bolster innovation and product development.
Capital Expenditure Plans and Funding Strategy
The company plans a significant capital expenditure of ₹200-300 crores over the next three years. This investment will be allocated towards both essential maintenance and modernization, typically ₹40-50 crores annually, as well as growth-oriented opportunities. The funding for these investments will primarily come from internal accruals, supported by the company's strong balance sheet. The future growth capex is expected to yield an asset turnover of 1.25 to 1.5 times.
Market Outlook and Risk Management
Management acknowledged the persistent volatility in the market environment and demand patterns, particularly in the agrochemical sector, but noted signs of stabilization. The company's strategy involves navigating these uncertainties through agile production, constant emphasis on volumes and market share, and prudent working capital management. Despite Chinese competition, Excel maintains a very limited direct supply chain exposure to China and focuses on being a preferred supplier in its key product segments.
Commitment to Sustainability and Operational Excellence
Excel Industries emphasizes health, safety, and environment management, with 48% of its total electricity requirements sourced from renewable sources. The company aims to maintain EBITDA margins between 13% and 15% in the medium term by focusing on operational efficiency, optimizing product mix, and strengthening its presence in high-margin specialty chemicals. This commitment underpins a resilient and sustainable business model.